As the first multinational pharmaceutical enterprise with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 433 products, over 1,000 dosage forms, and covers 30 medical specialties and 201 therapeutic classes, accounting for 66% of the market. The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported net sales totaled BRL 5.7 billion in 2020 and the Group employs over 7,600 people.